Chronic myeloid leukemia in chronic phase responding to imatinib: the occurrence of additional cytogenetic abnormalities predicts disease progression.

Source:http://linkedlifedata.com/resource/pubmed/id/12651263

Download in:

View as

General Info

PMID
12651263